X-116172674-AT-ATT
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The NM_000686.5(AGTR2):c.402dupT(p.Ile135TyrfsTer7) variant causes a frameshift change. The variant allele was found at a frequency of 0.000441 in 1,208,111 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 162 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00035 ( 0 hom., 9 hem., cov: 23)
Exomes 𝑓: 0.00045 ( 0 hom. 153 hem. )
Consequence
AGTR2
NM_000686.5 frameshift
NM_000686.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.16
Publications
7 publications found
Genes affected
AGTR2 (HGNC:338): (angiotensin II receptor type 2) The protein encoded by this gene belongs to the G-protein coupled receptor 1 family, and functions as a receptor for angiotensin II. It is an intergral membrane protein that is highly expressed in fetus and in neonates, but scantily in adult tissues, except brain, adrenal medulla, and atretic ovary. This receptor has been shown to mediate programmed cell death and this apoptotic function may play an important role in developmental biology and pathophysiology. Mutations in this gene are been associated with X-linked cognitive disability. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and SARS-CoV-2 infection results in down-regulation of angiotensin converting enzyme-2 (ACE2) receptors, the effects of which, triggers serious inflammatory lesions in the tissues involved, primarily in the lungs. The inflammatory reaction appears to be mediated by angiotensin II derivatives, including the angiotensin AT2 receptor which has been found to be upregulated in bronchoalveolar lavage samples from Coronavirus disease 2019 (COVID19) patients. [provided by RefSeq, Jul 2020]
AGTR2 Gene-Disease associations (from GenCC):
- non-syndromic X-linked intellectual disabilityInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
- X-linked complex neurodevelopmental disorderInheritance: XL Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BS2
High Hemizygotes in GnomAd4 at 9 XL gene
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| AGTR2 | ENST00000371906.5 | c.402dupT | p.Ile135TyrfsTer7 | frameshift_variant | Exon 3 of 3 | 1 | NM_000686.5 | ENSP00000360973.4 | ||
| AGTR2 | ENST00000681852.1 | c.402dupT | p.Ile135TyrfsTer7 | frameshift_variant | Exon 2 of 2 | ENSP00000505750.1 | ||||
| AGTR2 | ENST00000680409.1 | n.870dupT | non_coding_transcript_exon_variant | Exon 1 of 1 |
Frequencies
GnomAD3 genomes AF: 0.000353 AC: 39AN: 110551Hom.: 0 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
39
AN:
110551
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000350 AC: 64AN: 182958 AF XY: 0.000370 show subpopulations
GnomAD2 exomes
AF:
AC:
64
AN:
182958
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000450 AC: 494AN: 1097560Hom.: 0 Cov.: 31 AF XY: 0.000421 AC XY: 153AN XY: 363022 show subpopulations
GnomAD4 exome
AF:
AC:
494
AN:
1097560
Hom.:
Cov.:
31
AF XY:
AC XY:
153
AN XY:
363022
show subpopulations
African (AFR)
AF:
AC:
7
AN:
26382
American (AMR)
AF:
AC:
9
AN:
35200
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
19372
East Asian (EAS)
AF:
AC:
1
AN:
30195
South Asian (SAS)
AF:
AC:
8
AN:
54129
European-Finnish (FIN)
AF:
AC:
3
AN:
40515
Middle Eastern (MID)
AF:
AC:
0
AN:
4135
European-Non Finnish (NFE)
AF:
AC:
449
AN:
841556
Other (OTH)
AF:
AC:
15
AN:
46076
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
19
38
58
77
96
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.000353 AC: 39AN: 110551Hom.: 0 Cov.: 23 AF XY: 0.000274 AC XY: 9AN XY: 32889 show subpopulations
GnomAD4 genome
AF:
AC:
39
AN:
110551
Hom.:
Cov.:
23
AF XY:
AC XY:
9
AN XY:
32889
show subpopulations
African (AFR)
AF:
AC:
3
AN:
30337
American (AMR)
AF:
AC:
8
AN:
10337
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2625
East Asian (EAS)
AF:
AC:
0
AN:
3504
South Asian (SAS)
AF:
AC:
0
AN:
2625
European-Finnish (FIN)
AF:
AC:
0
AN:
5899
Middle Eastern (MID)
AF:
AC:
0
AN:
235
European-Non Finnish (NFE)
AF:
AC:
28
AN:
52815
Other (OTH)
AF:
AC:
0
AN:
1497
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
May 06, 2020
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.